Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 285-377-1 | CAS number: 85085-48-9 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Melaleuca alternifolia, Myrtaceae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- Non-GLP study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test: The study was conducted to determine the acute oral LD50 value of tea tree oil in the albino rat, according to the method of Litchfield and Wilcoxon (A Simplified Method of Evaluating Dose-Effect Experiments, J.T. Litchfield Jr and F. Wilcoxon, J. Pharmacol. 1949).
- Short description of test conditions: The test item (diluted with peanut oil) was administered by gavage over a range of dose levels to groups of five male and female rats. Toxicity to both SPF and non-SPF animals was investigated.
- Parameters analysed / observed: Mortality and clinical signs of toxicity or abnormal behaviour. - GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Melaleuca alternifolia, ext.
- EC Number:
- 285-377-1
- EC Name:
- Melaleuca alternifolia, ext.
- Cas Number:
- 85085-48-9
- Molecular formula:
- Not applicable (a generic molecular formula cannot be provided for this specific UVCB substance).
- IUPAC Name:
- Essential oil of melaleuca alternifolia
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- - Batch no.: 88/375
- Purity: 100%
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Source: The source of the SPF (specific pathogen free) rats was the Animal Resources Centre, W.A. The source of the non-SPF (non specific pathogen free) rats was Animal Services, Monash University, Victoria.
- Age at study initiation: The age of the test animals was not reported.
- Weight at study initiation: Between 146 and 219 grams.
- Fasting period before study: The animals were starved 24 hours before administration of the test sample.
- Housing: Housing conditions were not reported.
- Diet and water: Rat and mouse cubes and tap water ad libitum.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- peanut oil
- Details on oral exposure:
- - Concentration in vehicle: The test sample was diluted with peanut oil w/w at 3 different concentrations: 1/3, 1/4 and 1/5.
- No justification was provided for the choice of vehicle (although it is considered to be appropriate). - Doses:
- SPF Rats: Four groups of SPF rats were administered 3, 2.75, 2.6 and 2.5 ml/kg of test sample by gavage, using an intragastric cannula attached to a Yale glass syringe.
Non-SPF Rats: Five groups of non-SPF rats were administered 2.4, 2.25, 2.15, 2.10 and 1.70 ml/kg of test sample by gavage, using an intragastric cannula attached to a Yale glass syringe. - No. of animals per sex per dose:
- 5 male and 5 female per dose.
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days.
- The mortality rates and observed toxic signs were recorded for each group. - Statistics:
- LD50 values were determined with 95% confidence limits.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2.6 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 2.5 - <= 2.704
- Remarks on result:
- other: SPF rats
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1.9 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1.83 - <= 1.98
- Remarks on result:
- other: Non-SPF rats
- Mortality:
- SPF Rats: The groups which received 3, 2.75, 2.6 and 2.5 ml/kg of test material yielded 70%, 70%, 90% and 30% deaths respectively (See Table 1 in 'Any other information on results').
Non-SPF Rats: The groups which received 2.4, 2.25, 2.15, 2.10 and 1.70 ml/kg of test material yielded 100%, 100%, 80%, 30% and 60% deaths respectively. - Clinical signs:
- other: SPF Rats: Animals which survived generally exhibited a lack of tonus in the forelimbs, which disappeared gradually. Moribund animals had weeping eyes and bloodied noses. Non-SPF Rats: The surviving animals exhibited similar symptoms to the SPF animals.
- Other findings:
- The major non-lethal reaction caused by the test sample was a complete lack of muscular tone in the forelimbs.
Any other information on results incl. tables
SPF rats: The slope function of the line, determined with 95% confidence limits, was found to be 1.08 (0.99 to 1.18).
Non-SPF rats: The slope function of the line, determined with 95% confidence limits, was found to be 1.09 (1.007 to 1.174).
There was a difference in toxicity observed between the two sources of rat used in the study, however it was noted that the slopes of the dose-response relationships were found to be almost identical (see attached Fig. 1).
Table 1. Summary of mortalities and observations in SPF and non-SPF rats.
|
Dose (ml/kg) |
Sex (M/F) |
Number of mortalities per 5 animals |
Day of death |
Observations |
SPF rats |
2.5 |
M |
0 |
N/A |
30% deaths in 14 days. One male and one female had impaired mobility in forelimbs (no tonus) after 24 hours, which disappeared after 48 hours. Moribund animals had weeping eyes and bloodied noses. |
F |
3 |
1-2 |
|||
2.6 |
M |
4 |
1-2 |
90% deaths in 14 days. The remaining rat had impaired mobility in forelimbs (no tonus) which disappeared after 4 days. Moribund animals had weeping eyes and bloodied noses. |
|
F |
5 |
1-2 |
|||
2.75 |
M |
4 |
1 |
70% deaths in 14 days. Surviving animals had their mobility restricted (no tonus) which disappeared after 72 hours. Moribund animals had weeping eyes and bloodied noses. |
|
F |
3 |
1, 3 |
|||
3.0 |
M |
4 |
1 |
70% deaths in 14 days. Surviving animals had their mobility restricted in their forelimbs (no tonus) which gradually disappeared over 4 days. Moribund animals had weeping eyes and bloodied noses. |
|
F |
3 |
1, 3, 6 |
|||
Non-SPF rats |
1.7 |
M |
3 |
1-2 |
60% deaths in 14 days. All survivors had a lack of tonus in front limbs, which disappeared after 3 days. Moribund animals had weeping eyes and bloodied noses. |
F |
3 |
3-4 |
|||
2.1 |
M |
1 |
3 |
30% deaths in 14 days. All survivors had a lack of tonus which disappeared after 4 days, except one female who did not recover throughout the experimental period. Moribund animals had weeping eyes and bloodied noses. |
|
F |
2 |
1 |
|||
2.15 |
M |
4 |
1-2 |
80% deaths in 14 days. Surviving male and female had lack of tonus in forelimbs, which disappeared after 4 days. Moribund animals had weeping eyes and bloodied noses. |
|
F |
4 |
1-2 |
|||
2.25 |
M |
5 |
1, 3-4 |
100% deaths in 14 days. Moribund animals had weeping eyes and bloodied noses. |
|
F |
5 |
2-3 |
|||
2.4 |
M |
5 |
1-3 |
100% deaths in 14 days. Moribund animals had weeping eyes and bloodied noses. |
|
F |
5 |
1, 3 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LD50 of Tea Tree Oil was determined in two environmentally derived types of Sprague Dawley rat, and was found to be 2.6 ml/kg in SPF rats and 1.9 ml/kg in non-SPF rats (equivalent to 1691 mg/kg bw). The sample caused weeping eyes, bloodied noses and a lack of tonus in the forelimbs of those animals which survived.
- Executive summary:
The acute toxicity of Tea Tree Oil by the oral route to rats was assessed according to the method of Litchfield and Wilcoxon (1949). Groups of 5 male and 5 female Sprague Dawley rats (SPF and non-SPF) were used for the study. The test sample was diluted with peanut oil w/w at 3 different concentrations: 1/3, 1/4, 1/5. Four groups of SPF rats were administered 2.5, 2.6, 2.75 and 3 ml/kg of the test sample by gavage. Five groups of non-SPF rats were administered 1.70, 2.10, 2.15, 2.25 and 2.4 ml/kg of test sample by gavage. All animals were observed for any signs of toxicity or abnormal behaviour during the experimental period of 14 days. The LD50 of Tea Tree Oil was determined to be 2.6 ml/kg bodyweight in SPF rats and 1.9 ml/kg bodyweight in non-SPF rats (equivalent to 1691 mg/kg bw). The sample caused weeping eyes, bloodied noses and a lack of tonus in the forelimbs of those animals which survived.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.